Straumann Holding AG Goodwill and Intangible Assets 2012-2024 | SAUHY

Straumann Holding AG goodwill and intangible assets from 2012 to 2024. Goodwill and intangible assets can be defined as the sum of all intangible asset fields
  • Straumann Holding AG goodwill and intangible assets for the quarter ending December 31, 2024 were $1.027B, a 40.46% increase year-over-year.
  • Straumann Holding AG goodwill and intangible assets for 2024 were $1.027B, a 1.53% increase from 2023.
  • Straumann Holding AG goodwill and intangible assets for 2023 were $1.011B, a 24.03% increase from 2022.
  • Straumann Holding AG goodwill and intangible assets for 2022 were $0.815B, a 16.62% increase from 2021.
Straumann Holding AG Annual Goodwill and Intangible Assets
(Millions of US $)
2024 $1,027
2023 $1,011
2022 $815
2021 $699
2020 $694
2019 $748
2018 $667
2017 $639
2016 $319
2015 $257
2014 $75
2013 $78
2012 $192
2011 $114
Straumann Holding AG Quarterly Goodwill and Intangible Assets
(Millions of US $)
2024-12-31 $1,027
2023-12-31 $1,011
2022-12-31 $815
2021-12-31 $699
2021-06-30 $731
2020-12-31 $694
2020-06-30 $553
2019-12-31 $748
2018-12-31 $667
2017-12-31 $639
2017-06-30 $383
2016-12-31 $319
2016-06-30 $284
2015-12-31 $257
2014-12-31 $75
2013-12-31 $78
2013-06-30 $78
2012-12-31 $192
2012-06-30 $105
2011-12-31 $114
Sector Industry Market Cap Revenue
Medical Medical & Dental Supplies $20.753B $2.845B
The Straumann Group is a global leader in implant and restorative dentistry and oral tissue regeneration. In collaboration with leading clinics, research institutes and universities, Straumann researches, develops and manufactures dental implants, instruments, prosthetics and tissue regeneration products for use in tooth replacement and restoration solutions or to prevent tooth loss. Straumann currently employs approximately on thousand seven hundred ninety people worldwide and its products and services are available in more than sixty countries through its broad network of distribution subsidiaries and partners.
Stock Name Country Market Cap PE Ratio
McKesson (MCK) United States $88.910B 21.47
Becton Dickinson (BDX) United States $49.385B 12.23
Cardinal Health (CAH) United States $36.396B 19.06
Labcorp (LH) United States $20.246B 16.42
Cooper (COO) United States $15.859B 21.03
West Pharmaceutical Services (WST) United States $14.979B 31.40
Align Technology (ALGN) United States $12.512B 24.84
Henry Schein (HSIC) United States $8.682B 14.89
Merit Medical Systems (MMSI) United States $5.621B 27.17
DENTSPLY SIRONA (XRAY) United States $3.159B 9.43
CONMED (CNMD) United States $1.734B 12.98
STAAR Surgical (STAA) United States $0.930B 0.00
Lifevantage (LFVN) United States $0.166B 17.14
Pro-Dex (PDEX) United States $0.149B 16.29